MAPT and Alzheimer disease: Compared with the age-matched wild-type controls, a significantly increased accumulation of hyperphosphorylated tau (at Thr231 and Thr205) was detected in the MS subset of the AD mice (sFig. 1), which confirmed the vulnerability of MS to tau pathology.